Central Sensitization Inventory
The Central Sensitization Inventory (CSI) is a 25-item self-report screening instrument developed by Mayer and colleagues in 2012 to identify patients with central sensitization—a condition characterized by amplification of pain signaling and hypersensitivity to sensory stimuli. The CSI captures the constellation of symptoms including widespread pain, sleep disturbance, cognitive dysfunction, and autonomic dysregulation associated with central sensitization syndromes such as fibromyalgia, chronic fatigue syndrome, and post-traumatic stress disorder.
Source record
Citations copied verbatim from the method’s source record. No claim-level verification is inferred from them.
- Mayer, T.G., Neblett, R., Cohen, H., et al. (2012). The development and psychometric validation of the Central Sensitization Inventory. Pain Practice, 12(4), 276-285. · DOI 10.1111/j.1533-2500.2011.00493.x
- Neblett, R., Cohen, H., Choi, Y., Hardin, J.W., Mayer, T.G., Gonder-Frederick, L.A., & Mayer, J.M. (2013). The Central Sensitization Inventory (CSI): Establishing clinically significant values for identifying central sensitization in an outpatient chronic pain population. Journal of Pain, 14(5), 438-445. · DOI 10.1016/j.jpain.2012.11.012
- Schilling, J.M., Koh, S.E., Tully, A.S., et al. (2018). Central sensitization phenotyping in patients with knee osteoarthritis. Clinical Journal of Pain, 34(4), 296-302. · URL
Curated claims
Claims persisted in the evidence ledger, each with its own assessment.
This view does not invent a claim assessment when the ledger has none.
Related methods
Generated from the method graph and shown as machine-suggested relations — no evidence claim is inferred.